The brain cancer, glioblastoma, is a fierce and formidable opponent. Its millions of victims include Senator John McCain, President Biden's son, Beau, and famed film critic Gene Siskel, to name just a few. Most patients succumb ...
Dec 21, 2022
0
75
A vaccine (DCVax-L), trialed at King's College Hospital and other centers around the world, using patients' immune cells to target brain cancer can extend survival by many months or, in some cases, years, the final unblinded ...
Nov 21, 2022
0
82
A significant obstacle to treating brain cancer is not the cancer, but the brain itself.
Nov 11, 2022
0
62
In a new study, scientists have uncovered the mechanics of the blood-tumor barrier, one of the most significant obstacles to improving treatment efficacy and preventing the return of cancerous cells. The research team, led ...
Nov 1, 2022
0
603
Australian scientists have developed a world-first map showing gene activity changes in diverse human brain cell types from pre-birth to adulthood. By having this map of normal brain cell development, researchers will now ...
Nov 1, 2022
0
102
Despite significant advances, mortality from brain tumors remains high with five-year survival rates of 36%, according to the National Cancer Institute. More accurate diagnoses might improve the situation, but tissue biopsies ...
Sep 28, 2022
0
111
Luckily, the brain has a filter that protects it and the rest of the central nervous system from foreign elements like pathogens that can damage the tissue.
Aug 2, 2022
0
35
A gene that University of Virginia (UVA) Health researchers have discovered is responsible for the deadliest type of brain tumor is also responsible for two forms of childhood cancer, the scientists have found.
Jul 28, 2022
0
857
As a potential alternative for drug testing without lab animals, researchers at KTH Royal Institute of Technology developed and successfully tested a 3D model of living brain cancer that surmounts one of the biggest challenges ...
Feb 23, 2022
0
69
UNC Lineberger Comprehensive Cancer Center researchers have demonstrated that a novel combination of two drugs that act as targeted inhibitors, delivered in a nanoparticle formulation, extend the survival of mice with medulloblastoma. ...
Jan 26, 2022
0
92
